|

|
|
FP7 ERA-NET on
Nanosafety
Safe
Implementation of Innovative
Nanoscience
and Nanotechnology
|
|
|
|
Experimental
|
|
Lead: TU Dresden
|
|
Aim of the WP E is to collect experimental data on the human exposure
to atomized MNM, because spraying of MNM suspensions is the most
important way of exposure to MNM. A test rig will be developed which
enables for the stable and reproducible generation of aerosols from MNM
suspended in various liquids under different conditions. The test rig
for the characterization of aerosols from spray processes will employ a
flow channel and a nozzle for atomizing liquids containing MNM. To
simulate practical relevant spray scenarios an impaction plate will be
installed in the flow channel. The aerosol which bypasses this
impaction plate will be sampled for the measurement of its size
distribution and used for cell culture exposure. Optionally an
electrostatic classifier (DMA) or a cascade impactor will be employed
to use defined particle size fractions for subsequent exposure and for
the size selective preparation of the particles on SEM/TEM-grids.
Samples of cell models (monolyer cultures, human 3D airway models and
PCLS) will be exposed for assessing particle size distribution in the
chemical surrounding of an airway epithelium, and additionally for
measurement of the intracellular dose. Cultivation of human 3D airway
models as well as chemical and particle analysis will be performed by
BfR and Gaiker. Analysis will deliver the MNM content of different size
fractions of spray aerosols and the influence of the different chemical
surroundings of monolayer alveolar and bronchial cultures, human 3D
airway epithelium and textiles on particle size distribution. Analysis
of the airway models will further reveal MNM amount occurring at the
cellular surface/within the cellular membrane and within the cell.
|
|
|
|
|
|
|

|

|
|
This project is part
of the SIINN ERA-NET and is funded under the ERA-NET scheme
of the Seventh Framework Programme of the European Commission,
Research
Directorate - General, Grant Agreement No. 265799
|
|